Lv3
350 积分 2025-07-20 加入
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
59分钟前
待确认
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
1小时前
已完结
Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?
1小时前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
2天前
已完结
Benchmarking Oncologic Outcomes of Liver Resection For Colorectal Metastases LiverMetSurvey-based Reference Values For Evaluating Alternative Treatments
2个月前
已完结
Two-stage Hepatectomy Versus Liver Transplantation for Patients with Marginally Resectable Extensive Bilobar Colorectal Liver Metastases
2个月前
已完结
Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trial
2个月前
已完结
Laparoscopic Microwave Ablation vs Resection for Small Solitary Colorectal Liver Metastases: Multicenter Analysis of Long-Term Results
2个月前
已关闭
Selection for local treatment and outcomes of surgical resection in patients with synchronous colorectal liver metastases: A nationwide population-based study
2个月前
已完结
Anti-EGFR plus chemotherapy vs. chemotherapy alone in RAS wild-type colorectal liver metastases: A meta-analysis of survival outcomes in resectable and unresectable settings
2个月前
已完结
皖公网安备34019202002308
